Influence of controlled hypotension using esmolol and sodium nitroprusside on natriuretic peptides in patients undergoing endonasal sinus surgery

European Journal of Anaesthesiology

Volumn 24, Issue 6, 2007, Pages 529-534

  Mengistu, A M ^a   Wolf, M W ^a   Boldt, J ^a   Rohm K D ^a   Suttner, S W ^a   Piper, S N ^a  

^a KLINIKUM LUDWIGSHAFEN   (Germany)

Author keywords

Atrial natriuretic factor; Brain; Esmolol; Hypotension controlled; Natriuretic peptide; Nitroprusside; Surgery, nasal

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; ESMOLOL; NITROPRUSSIDE SODIUM;

ADULT; ARTICLE; BLEEDING; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HUMAN; HYPOTENSION; MALE; MEAN ARTERIAL PRESSURE; OPERATION DURATION; PARANASAL SINUS; PERFUSION PRESSURE; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PROTEIN BLOOD LEVEL;

ADRENERGIC BETA-ANTAGONISTS; ADULT; ANALYSIS OF VARIANCE; ATRIAL NATRIURETIC FACTOR; FEMALE; HUMANS; HYPOTENSION, CONTROLLED; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; NATRIURETIC PEPTIDE, BRAIN; NITROPRUSSIDE; PARANASAL SINUSES; PROPANOLAMINES; SURGICAL PROCEDURES, ELECTIVE; VASODILATOR AGENTS;

EID: 34249102214     PISSN: 02650215     EISSN: 13652346     Source Type: Journal    
DOI: 10.1017/S0265021506002286     Document Type: Article

References (30)

1. Habler O. Controlled hypotension. Anaesthesist 2000; 49: 687-689.
2. Sharrock NE, Mineo R, Urquhart B, Salvati EA. The effect of two levels of hypotension on intraoperative blood loss during total hip arthroplasty performed under lumbar epidural anesthesia. Anesth Analg 1993; 76: 580-584.
3. Piper SN, Haisch G, Kumle B et al. Effects of esmolol- and sodium nitroprusside-induced controlled hypotension on hepatocellular integrity in patients undergoing endonasal sinus surgery. Anasthesiol Intensivmed Notfallmed Schmerzther 2003; 38: 781-786.
4. Piper SN, Suttner SW, Maleck WH, Kumle B, Haisch G, Boldt J. Effects of sodium nitroprusside-induced controlled hypotension on pancreatic function assessed by pancreatitis-associated protein in patients undergoing radical prostatectomy. Eur J Anaesthesiol 2002; 19: 609-613.
5. de Bold AJ. Atrial natriuretic factor: a hormone produced by the heart. Science 1985; 230: 767-770.
6. Sudoh T, Kangawa K, Minamino N, Matsuo H. A new natriuretic peptide in porcine brain. Nature 1988; 332: 78-81.
7. Yasue H, Yoshimura M, Sumida H et al. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation 1994; 90: 195-203.
8. Silver MA. The natriuretic peptide system: kidney and cardiovascular effects. Curr Opin Nephrol Hypertens 2006; 15: 14-21.
9. Levin ER, Gardner DG, Samson WK. Natriuretic peptides. N Engl J Med 1998; 339: 321-328.
10. Richards AM, Lainchbury JG, Troughton RW, Espiner EA, Nicholls MG. Clinical applications of B-type natriuretic peptides. Trends Endocrinol Metab 2004; 15: 170-174.
11. Doust JA, Pietrzak E, Dobson A, Glasziou P. How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review. BMJ 2005; 330: 625.
12. Maeda K, Tsutamoto T, Wada A, Hisanaga T, Kinoshita M. Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction. Am Heart J 1998; 135: 825-832.
13. Maisel AS, Krishnaswamy P, Nowak RM et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002; 347: 161-167.
14. Kragelund C, Gronning B, Kober L, Hildebrandt P, Steffensen R. N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease. N Engl J Med 2005; 352: 666-675.
15. ten Wolde M, Tulevski II, Mulder JW et al. Brain natriuretic peptide as a predictor of adverse outcome in patients with pulmonary embolism. Circulation 2003; 107: 2082-2084.
16. Yeh HM, Lau HP, Lin JM, Sun WZ, Wang MJ, Lai LP. Preoperative plasma N-terminal pro-brain natriuretic peptide as a marker of cardiac risk in patients undergoing elective non-cardiac surgery. Br J Surg 2005; 92: 1041-1045.
17. Terasako K. Perioperative plasma concentrations of atrial and brain natriuretic peptides in patients undergoing hip arthroplasty. Anaesth Intens Care 2002; 30: 588-590.
18. Schlossmann J, Feil R, Hofmann F. Signaling through NO and cGMP-dependent protein kinases. Ann Med 2003; 35: 21-27.
19. Melo LG, Sonnenberg H. Effect of nitric oxide inhibition on secretion of atrial natriuretic factor in isolated rat heart. Am J Physiol 1996; 270: H306-H311.
20. Skvorak JP, Dietz JR. Endothelin and nitric oxide interact to regulate stretch-induced ANP secretion. Am J Physiol 1997; 273: R301-R306.
21. Keller N. Significance of adrenoceptor-mediated atrial natriuretic factor release in normal humans. Scand J Clin Lab Invest 1991; 51: 73-84.
22. Legault L, van Nguyen P, Holliwell DL, Leenen FH. Hemodynamic and plasma atrial natriuretic factor responses to cardiac volume loading in young versus older normotensive humans. Can J Physiol Pharmacol 1992; 70: 1549-1554.
23. Berlin I, Lechat P, Deray G et al. Beta-adrenoceptor blockade potentiates acute exercise-induced release of atrial natriuretic peptide by increasing atrial diameter in normotensive healthy subjects. Eur J Clin Pharmacol 1993; 44: 127-133.
24. van den Meiracker AH, Lameris TW, van de Ven LL, Boomsma F. Increased plasma concentration of natriuretic peptides by selective beta1-blocker bisoprolol. J Cardiovasc Pharmacol 2003; 42: 462-468.
25. Davis ME, Richards AM, Nicholls MG, Yandle TG, Frampton CM, Troughton RW. Introduction of metoprolol increases plasma B-type cardiac natriuretic peptides in mild, stable heart failure. Circulation 2006; 113: 977-985.
26. Hryniewicz K, Androne AS, Hudaihed A, Katz SD. Comparative effects of carvedilol and metoprolol on regional vascular responses to adrenergic stimuli in normal subjects and patients with chronic heart failure. Circulation 2003; 108: 971-976.
27. Kohno M, Yasunari K, Matsuura T, Murakawa K, Takeda T. Circulating atrial natriuretic polypeptide in essential hypertension. Am Heart J 1987; 113: 1160-1163.
28. Ferri C, Luparini RL, Giarrizzo G et al. Effects of active orthostatism on blood levels of atrial natriuretic peptide in the healthy subject. Medicina (Firenze) 1989; 9: 172-173.
29. Freitas J, Santos R, Azevedo E, Carvalho M, Rocha-Goncalves F. Neurohormonal behavior during prolonged orthostatic stress in normotensive subjects. Rev Port Cardiol 2005; 24: 81-86.
30. Tsubo T, Isozaki K, Sato T, Araki I, Ishihara H, Matsuki A. Hemodynamic and endocrine responses to prostaglandin E1 induced hypotension during enflurane anesthesia in surgical patients - evaluation by transesophageal echocardiography. Masui 1993; 42: 66-70.